Meetings - The ASCO Post

This is Part 3 of New Directions in Nonmetastatic Non–Small Cell Lung Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable. In this video, Drs. He...

lung cancer

/ New Directions in Nonmetastatic Non–Small Cell Lung Cancer

PD-L1–Negative Early-Stage NSCLC

This is Part 2 of New Directions in Nonmetastatic Non–Small Cell Lung Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable. In this video, Drs. He...

lung cancer

/ New Directions in Nonmetastatic Non–Small Cell Lung Cancer

IO Strategies for Resectable NSCLC

This is Part 1 of New Directions in Nonmetastatic Non–Small Cell Lung Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable. In this video, Drs. He...

New Directions in Nonmetastatic Non–Small Cell Lung Cancer

EGFR-Mutated Early-Stage NSCLC

PD-L1–Negative Early-Stage NSCLC

IO Strategies for Resectable NSCLC

Adjuvant Pembrolizumab in Renal Cell Carcinoma: Overall Survival in KEYNOTE-564

Combined ICI and VEGF Inhibitor Trials in Cancer Cardiovascular Eligibility Criteria and Adverse Event Reporting

Risk of T-Cell and Second Primary Malignant Neoplasms After CAR T-Cell Therapy

Lack of Research Focused on Older Adults With Cancer May Be Contributing to Disparities in Care

Breast Cancer Survivors: Relationship Satisfaction and Emotional and Physical Well-Being